A case of Mycobacterium scrofulaceum osteomyelitis of the right wrist

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 5, 2000, Pages 678-681

  Phoa, L L ^b   Khong, K S ^b   Thamboo, T P ^b   Sin Fai Lam, K N ^a  

^a ALEXANDRA HOSPITAL   (Singapore)

^b NONE

Author keywords

Atypical; Diabetes; Erosive; Synovectomy; Tuberculosis

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; MALE; MYCOBACTERIUM SCROFULACEUM; OSTEOMYELITIS; SYNOVECTOMY; TREATMENT FAILURE; TUBERCULOUS OSTEOMYELITIS; WRIST DISEASE;

EID: 0033763779     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Communicable Disease Surveillance Report. Ministry of Health Singapore, 1998:9.
2. rd ed. NY: Churchill Livingstone, 1985:1918.
3. Wolinsky E. Non tuberculous mycobacteria and associated diseases. Am Rev Resp Dis 1979; 119:107-39.
4. Good R C, Snider D E Jr. From the Centres for Disease Control. Isolation of non tuberculous mycobacteria in US 1980. J Infect Dis 1982; 146:829-33.
5. Young L S, Inderfield C B, Berlin O G, Gottlieb M S. Mycobacterial infections in AIDS patients with an emphasis on MAC. Rev Infect Dis 1986; 8:1024-33.
6. Sanders J W, Walsh A D, Snider R L, Sahn E E. Disseminated Mycobacterium scrofulaceum infection: A potentially treatable complication of AIDS. Clin Infect Dis 1995; 20:549-56.
7. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria (Official Statement of the American Thoracic Society). Am Rev Resp Dis 1990; 142:940-53.
8. Hsueh P R, Hsiue T R, Jam J J, Ho S W, Hsieh W C. Disseminated infection due to M. scrofulaceum in an immunocompetent host. Clin Infect Dis 1996; 22:159-61.
9. LeMense G P, VanBakel A B, Crumbley A J III, Judson M A. M. scrofulaceum infection as lung nodules in a heart transplant patient. Chest 1994; 106:1918-20.
10. Hoffman P C, Fraser D W, Robicsek F, O'Bar P R, Mauney C U. Two outbreaks of sternal wound infection due to organisms of Mycobacterium fortuitum complex. J Infect Dis 1981; 143:533-42.
11. Szabo I. Mycobacteria chelonei endemy after heart surgery with fatal consequences. Am Rev Resp Dis 1980; 121:607.
12. Lincoln E M, Gilbert L A. Diseases in children due to mycobaeteria other than Mycobacterium tuberculosis. Am Rev Resp Dis 1972; 105:683-714.
13. Wolinsky E. Mycobacteria diseases other than tuberculosis. Clin Infect Dis 1992; 15:1-12.
14. Brown B A, Wallace R J Jr, Onyi G O. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother 1992; 36:1987-990.
15. Lindeboom J A, de Lange J, van den Akker H P. Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87:50-4.
16. Picken R N, Tsang A Y, Yang H L. Speciation of organisms within the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex (MAIS) based on restriction fragment length polymorphism. Mol Cell Probes 1988; 2:289-304.
17. Swanson D S, Pan X, Musser J M. Identification and subspecific differentiation of Mycobacterium scrofulaceum by automated sequencing of a region of the gene. (hsp65) encoding a 65-kilodalton heat shock protein. J Clin Microbiol 1996; 34:3151-9.